CN102526326A - Traditional Chinese medicine for treating postmenopausal osteoporosis and preparation method thereof - Google Patents
Traditional Chinese medicine for treating postmenopausal osteoporosis and preparation method thereof Download PDFInfo
- Publication number
- CN102526326A CN102526326A CN2012100276525A CN201210027652A CN102526326A CN 102526326 A CN102526326 A CN 102526326A CN 2012100276525 A CN2012100276525 A CN 2012100276525A CN 201210027652 A CN201210027652 A CN 201210027652A CN 102526326 A CN102526326 A CN 102526326A
- Authority
- CN
- China
- Prior art keywords
- weight portions
- chinese medicine
- medicine composition
- radix
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 128
- 208000001685 postmenopausal osteoporosis Diseases 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title description 10
- 239000000203 mixture Substances 0.000 claims abstract description 106
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 57
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 51
- 210000000582 semen Anatomy 0.000 claims description 44
- 238000010992 reflux Methods 0.000 claims description 36
- 239000000843 powder Substances 0.000 claims description 33
- 239000007788 liquid Substances 0.000 claims description 28
- 238000002156 mixing Methods 0.000 claims description 21
- 229940079593 drug Drugs 0.000 claims description 20
- 239000006188 syrup Substances 0.000 claims description 17
- 235000020357 syrup Nutrition 0.000 claims description 17
- 239000002253 acid Substances 0.000 claims description 16
- 230000001476 alcoholic effect Effects 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 14
- 238000009835 boiling Methods 0.000 claims description 13
- 239000002552 dosage form Substances 0.000 claims description 12
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 claims description 11
- 230000002421 anti-septic effect Effects 0.000 claims description 11
- 229940085605 saccharin sodium Drugs 0.000 claims description 11
- 241000903946 Clematidis Species 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 9
- 229920002472 Starch Polymers 0.000 claims description 8
- 238000002347 injection Methods 0.000 claims description 8
- 239000007924 injection Substances 0.000 claims description 8
- 239000008107 starch Substances 0.000 claims description 8
- 235000019698 starch Nutrition 0.000 claims description 8
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 7
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 7
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 7
- 235000008504 concentrate Nutrition 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000000465 moulding Methods 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 235000011837 pasties Nutrition 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- -1 suspensoid Substances 0.000 claims description 5
- 239000007900 aqueous suspension Substances 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 229940098465 tincture Drugs 0.000 claims description 3
- 238000010255 intramuscular injection Methods 0.000 claims description 2
- 239000007927 intramuscular injection Substances 0.000 claims description 2
- 238000001990 intravenous administration Methods 0.000 claims description 2
- 238000010253 intravenous injection Methods 0.000 claims description 2
- 238000010254 subcutaneous injection Methods 0.000 claims description 2
- 239000007929 subcutaneous injection Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 42
- 230000008901 benefit Effects 0.000 abstract description 4
- 206010059866 Drug resistance Diseases 0.000 abstract description 3
- 241000405414 Rehmannia Species 0.000 abstract description 2
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000110637 Cuscuta chinensis Species 0.000 abstract 1
- 241000241550 Cyathula Species 0.000 abstract 1
- 241001116742 Drynaria Species 0.000 abstract 1
- 241000096284 Gynochthodes officinalis Species 0.000 abstract 1
- 240000007049 Juglans regia Species 0.000 abstract 1
- 235000009496 Juglans regia Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 241000488974 Loranthus Species 0.000 abstract 1
- 241000270708 Testudinidae Species 0.000 abstract 1
- 230000003071 parasitic effect Effects 0.000 abstract 1
- 235000020234 walnut Nutrition 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 56
- 210000000988 bone and bone Anatomy 0.000 description 51
- 239000008280 blood Substances 0.000 description 42
- 210000004369 blood Anatomy 0.000 description 41
- 230000007812 deficiency Effects 0.000 description 36
- 210000004185 liver Anatomy 0.000 description 35
- 208000001132 Osteoporosis Diseases 0.000 description 32
- 238000011282 treatment Methods 0.000 description 28
- 210000000952 spleen Anatomy 0.000 description 23
- 241000700159 Rattus Species 0.000 description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 230000037182 bone density Effects 0.000 description 16
- 208000024891 symptom Diseases 0.000 description 16
- 208000002193 Pain Diseases 0.000 description 15
- 235000009508 confectionery Nutrition 0.000 description 15
- 201000010099 disease Diseases 0.000 description 15
- 210000003205 muscle Anatomy 0.000 description 14
- 230000036407 pain Effects 0.000 description 14
- 210000002966 serum Anatomy 0.000 description 13
- 230000006870 function Effects 0.000 description 12
- 229940011871 estrogen Drugs 0.000 description 11
- 239000000262 estrogen Substances 0.000 description 11
- 239000003390 Chinese drug Substances 0.000 description 9
- 230000011164 ossification Effects 0.000 description 9
- 108090000672 Annexin A5 Proteins 0.000 description 8
- 238000005728 strengthening Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 208000006386 Bone Resorption Diseases 0.000 description 7
- 206010021118 Hypotonia Diseases 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 208000017561 flaccidity Diseases 0.000 description 7
- 210000000629 knee joint Anatomy 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 208000006820 Arthralgia Diseases 0.000 description 6
- 208000008035 Back Pain Diseases 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 230000024279 bone resorption Effects 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 208000002173 dizziness Diseases 0.000 description 6
- 210000003414 extremity Anatomy 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 210000003127 knee Anatomy 0.000 description 6
- 210000003141 lower extremity Anatomy 0.000 description 6
- 230000008736 traumatic injury Effects 0.000 description 6
- CHZJRGNDJLJLAW-RIQJQHKOSA-N (8r,9s,13s,14s,16r,17r)-3-cyclopentyloxy-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthrene-16,17-diol Chemical compound C([C@@H]1[C@@H](C2=CC=3)CC[C@]4([C@H]1C[C@@H](O)[C@@]4(O)C#C)C)CC2=CC=3OC1CCCC1 CHZJRGNDJLJLAW-RIQJQHKOSA-N 0.000 description 5
- 208000009205 Tinnitus Diseases 0.000 description 5
- 208000031971 Yin Deficiency Diseases 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 210000001185 bone marrow Anatomy 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 230000009245 menopause Effects 0.000 description 5
- 229950007863 nilestriol Drugs 0.000 description 5
- 231100000886 tinnitus Toxicity 0.000 description 5
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 230000002440 hepatic effect Effects 0.000 description 4
- 201000001881 impotence Diseases 0.000 description 4
- 230000001009 osteoporotic effect Effects 0.000 description 4
- 230000002611 ovarian Effects 0.000 description 4
- 230000008506 pathogenesis Effects 0.000 description 4
- 230000002980 postoperative effect Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- 206010063659 Aversion Diseases 0.000 description 3
- 206010010356 Congenital anomaly Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 231100000111 LD50 Toxicity 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 230000004097 bone metabolism Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000009977 dual effect Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 239000007952 growth promoter Substances 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 230000003907 kidney function Effects 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 206010036596 premature ejaculation Diseases 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000020084 Bone disease Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000008717 functional decline Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 230000001456 gonadotroph Effects 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 210000004705 lumbosacral region Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000000963 osteoblast Anatomy 0.000 description 2
- 210000002997 osteoclast Anatomy 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 2
- 235000005282 vitamin D3 Nutrition 0.000 description 2
- 239000011647 vitamin D3 Substances 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 229940021056 vitamin d3 Drugs 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 206010018866 Haematospermia Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000008982 Hemospermia Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 201000002980 Hyperparathyroidism Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 102000003982 Parathyroid hormone Human genes 0.000 description 1
- 108090000445 Parathyroid hormone Proteins 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 208000010067 Pituitary ACTH Hypersecretion Diseases 0.000 description 1
- 208000020627 Pituitary-dependent Cushing syndrome Diseases 0.000 description 1
- 108010050808 Procollagen Proteins 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 206010039984 Senile osteoporosis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010058907 Spinal deformity Diseases 0.000 description 1
- 241000287181 Sturnus vulgaris Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 239000003741 agents affecting lipid metabolism Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000157 blood function Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000004154 complement system Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- XQRLCLUYWUNEEH-UHFFFAOYSA-L diphosphonate(2-) Chemical compound [O-]P(=O)OP([O-])=O XQRLCLUYWUNEEH-UHFFFAOYSA-L 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 239000000328 estrogen antagonist Substances 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000002436 femur neck Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000000527 greater trochanter Anatomy 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 210000001357 hemopoietic progenitor cell Anatomy 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000003688 hormone derivative Substances 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 230000004185 hypothalamic-pituitary-gonadal axis Effects 0.000 description 1
- 201000000916 idiopathic juvenile osteoporosis Diseases 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 238000011633 osteoporosis animal model Methods 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 239000000199 parathyroid hormone Substances 0.000 description 1
- 229960001319 parathyroid hormone Drugs 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 238000009527 percussion Methods 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 229950000688 phenothiazine Drugs 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Group | The example number | The whole body bone density | The waist bone density |
Blank control group | 12 | 0.142±0.019 | 0.235±0.0241 |
Matched group | 10 | 0.123±0.0151 1) | 0.182±0.041 1) |
Group | The example number | E 2(pg/ml) | ALP(U/l) | PICP(ug/l) |
Blank control group | 12 | 79±23 | 1.17±0.12 | 79±14 |
Model group | 10 | 58±151 1) | 1.04±0.05 1) | 82±9 |
Chinese drug-treated group | 11 | 78±18 2) | 1.13±0.06 2) | 94±12 2) |
The estrogen group | 11 | 82±19 1) | 1.13±0.05 3) | 96±17 |
Group | Number | Produce effects | Effectively | Invalid | Effective percentage |
The treatment group | 100 | 67 | 28 | 5 | 95% |
Matched group | 83 | 31 | 19 | 33 | 60.2% |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210027652 CN102526326B (en) | 2012-02-09 | 2012-02-09 | Traditional Chinese medicine for treating postmenopausal osteoporosis and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210027652 CN102526326B (en) | 2012-02-09 | 2012-02-09 | Traditional Chinese medicine for treating postmenopausal osteoporosis and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102526326A true CN102526326A (en) | 2012-07-04 |
CN102526326B CN102526326B (en) | 2013-07-17 |
Family
ID=46335146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210027652 Expired - Fee Related CN102526326B (en) | 2012-02-09 | 2012-02-09 | Traditional Chinese medicine for treating postmenopausal osteoporosis and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102526326B (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103191315A (en) * | 2013-04-26 | 2013-07-10 | 漯河医学高等专科学校 | Traditional Chinese medicine for treating postmenopausal osteoporosis |
CN103690671A (en) * | 2013-12-18 | 2014-04-02 | 陆吉松 | Achyranthes bidentata for strengthening tendons and bones and preparation method thereof |
CN103705831A (en) * | 2013-12-27 | 2014-04-09 | 柳州市工人医院 | Pharmaceutical composition for treating various symptoms before and after menopause and preparation method thereof |
CN104258294A (en) * | 2014-10-11 | 2015-01-07 | 青岛华仁技术孵化器有限公司 | Bone-strengthening powder |
CN104940540A (en) * | 2015-06-17 | 2015-09-30 | 杨风霞 | Traditional Chinese medicine preparation for treating postmenopausal osteoporosis and preparation method thereof |
CN105395806A (en) * | 2015-12-12 | 2016-03-16 | 杨献美 | A traditional Chinese medicine preparation for treating osteoporosis in postmenopausal women |
CN107006681A (en) * | 2016-01-28 | 2017-08-04 | 柳泓善 | Animal feed composition containing Chinese medicinal material extract |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100373497B1 (en) * | 2001-10-27 | 2003-02-25 | Jung Keun Kim | Extract of rehmanniae radix and pharmaceutical composition containing the same for facilitating bone formation of children and for prevention and treatment of bone diseases such as osteoporosis |
CN1736409A (en) * | 2004-08-19 | 2006-02-22 | 宋一兵 | Pills for treating hyperosteogeny of cervical vertebra and lumbar vertebra |
CN1879846A (en) * | 2006-04-30 | 2006-12-20 | 桂林天和药业股份有限公司 | A Chinese medicinal preparation for treating rheumatism, hyperosteogeny and osteoporosis and method for preparing same |
CN1961953A (en) * | 2005-11-11 | 2007-05-16 | 魏秀华 | Tablet with chain fern and black snake for treating bone disease |
CN101112445A (en) * | 2007-08-13 | 2008-01-30 | 毛继凯 | Chinese traditional medicine prescription for treating osteoporosis |
CN101450167A (en) * | 2007-12-07 | 2009-06-10 | 李勇 | Medicine composition for treating osteoporosis |
CN101953993A (en) * | 2010-08-27 | 2011-01-26 | 高燕 | Medicament for treating osteoporosis |
-
2012
- 2012-02-09 CN CN 201210027652 patent/CN102526326B/en not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100373497B1 (en) * | 2001-10-27 | 2003-02-25 | Jung Keun Kim | Extract of rehmanniae radix and pharmaceutical composition containing the same for facilitating bone formation of children and for prevention and treatment of bone diseases such as osteoporosis |
CN1736409A (en) * | 2004-08-19 | 2006-02-22 | 宋一兵 | Pills for treating hyperosteogeny of cervical vertebra and lumbar vertebra |
CN1961953A (en) * | 2005-11-11 | 2007-05-16 | 魏秀华 | Tablet with chain fern and black snake for treating bone disease |
CN1879846A (en) * | 2006-04-30 | 2006-12-20 | 桂林天和药业股份有限公司 | A Chinese medicinal preparation for treating rheumatism, hyperosteogeny and osteoporosis and method for preparing same |
CN101112445A (en) * | 2007-08-13 | 2008-01-30 | 毛继凯 | Chinese traditional medicine prescription for treating osteoporosis |
CN101450167A (en) * | 2007-12-07 | 2009-06-10 | 李勇 | Medicine composition for treating osteoporosis |
CN101953993A (en) * | 2010-08-27 | 2011-01-26 | 高燕 | Medicament for treating osteoporosis |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103191315A (en) * | 2013-04-26 | 2013-07-10 | 漯河医学高等专科学校 | Traditional Chinese medicine for treating postmenopausal osteoporosis |
CN103191315B (en) * | 2013-04-26 | 2014-08-20 | 漯河医学高等专科学校 | Traditional Chinese medicine for treating postmenopausal osteoporosis |
CN103690671A (en) * | 2013-12-18 | 2014-04-02 | 陆吉松 | Achyranthes bidentata for strengthening tendons and bones and preparation method thereof |
CN103705831A (en) * | 2013-12-27 | 2014-04-09 | 柳州市工人医院 | Pharmaceutical composition for treating various symptoms before and after menopause and preparation method thereof |
CN103705831B (en) * | 2013-12-27 | 2016-06-15 | 柳州市妇幼保健院 | A kind of pharmaceutical composition treating menopausal syndrome and preparation method thereof |
CN104258294A (en) * | 2014-10-11 | 2015-01-07 | 青岛华仁技术孵化器有限公司 | Bone-strengthening powder |
CN104940540A (en) * | 2015-06-17 | 2015-09-30 | 杨风霞 | Traditional Chinese medicine preparation for treating postmenopausal osteoporosis and preparation method thereof |
CN105395806A (en) * | 2015-12-12 | 2016-03-16 | 杨献美 | A traditional Chinese medicine preparation for treating osteoporosis in postmenopausal women |
CN107006681A (en) * | 2016-01-28 | 2017-08-04 | 柳泓善 | Animal feed composition containing Chinese medicinal material extract |
Also Published As
Publication number | Publication date |
---|---|
CN102526326B (en) | 2013-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102526326B (en) | Traditional Chinese medicine for treating postmenopausal osteoporosis and preparation method thereof | |
CN103169928B (en) | Externally applied traditional Chinese medicine composition for treating dysmenorrhea, as well as preparation method and application thereof | |
CN104587439A (en) | Traditional Chinese medicine preparation for treating yang-deficiency internal-cold type dysmenorrhea and preparation method thereof | |
CN103830555A (en) | Medicinal liquor as well as preparation method and use thereof | |
CN101507776B (en) | Traditional Chinese medicine preparation for treating kidney deficiency, waist and knees soreness and preparation method thereof | |
CN104983985B (en) | A kind of Chinese medicine preparation of Cure of depression | |
CN104013817A (en) | Conic gymnadenia tuber-sealwort-radix polygonati officinalis preparation and production method thereof | |
CN103550688B (en) | A kind of Chinese medicine composition for the treatment of cardiopalmus | |
CN103330837B (en) | Traditional Chinese medicine composition for curing osteoporosis of menopausal women | |
CN103212037B (en) | Traditional Chinese medicine for treating female endocrine disorder and preparation method of traditional Chinese medicine | |
CN102048913B (en) | Traditional Chinese medicine preparation for treating climacteric syndrome and preparation method thereof | |
CN104667199A (en) | Pharmaceutical preparation for treating mental anxiety and application of pharmaceutical preparation | |
CN104548049A (en) | Traditional Chinese medicine composition for treating senile osteoporosis and preparation method thereof | |
CN105327092B (en) | It is a kind of to treat the Chinese medicine composition and its application that cervical is had a sleepless night | |
CN103920058A (en) | Traditional Chinese medicine preparation for treating headache and preparation method thereof | |
CN104524524B (en) | Medicine treating osteoporosis and preparing method | |
CN103585414B (en) | Pharmaceutical composition for treating sciatica and osteoporosis | |
CN104857370A (en) | Traditional Chinese medicine composition for treating breast cancer | |
CN102552766B (en) | Traditional Chinese medicine used for treating postmenopausal osteoporosis, preparation method thereof, and administration method thereof | |
CN110339323A (en) | A kind of Chinese medicine composition and its preparation method and application for treating bradycardia | |
CN102614380B (en) | Traditional Chinese medicinal composition pulvis and tablets for treating primary osteoporosis, preparation method thereof and health-care product | |
CN103285108B (en) | Chinese medicinal composition treating lumbago | |
CN108310111B (en) | Traditional Chinese medicine formula for benefiting qi and nourishing blood, preparation method and application thereof, medicated diet for benefiting qi and nourishing blood and preparation method thereof | |
CN105169089A (en) | Traditional Chinese medicine pill for treating headache during menstruation and preparing method of traditional Chinese medicine pill | |
CN106177208A (en) | A kind of subhealth state that regulates causes the Chinese herbal and crude drugs preparations of insomnia agitation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SUN XIA Free format text: FORMER OWNER: LIU SIJUAN Effective date: 20130708 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Song Haiping Inventor after: Tan Weiyong Inventor after: Sun Xia Inventor before: Liu Sijuan |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 237221 LU'AN, ANHUI PROVINCE TO: 266071 QINGDAO, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: LIU SIJUAN TO: SONG HAIPING TAN WEIYONG SUN XIA |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130708 Address after: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 Minmetals building room 801 Patentee after: Sun Xia Address before: 237221, No. 35, Xia Jie Qiao street, Mount Holyoke County, Anhui Patentee before: Liu Sijuan |
|
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 237221, No. 35, Xia Jie Qiao street, Mount Holyoke County, Anhui Patentee after: Sun Xia Address before: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 Minmetals building room 801 Patentee before: Sun Xia |
|
ASS | Succession or assignment of patent right |
Owner name: HUANG YARONG Free format text: FORMER OWNER: SUN XIA Effective date: 20141231 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 237221 LU'AN, ANHUI PROVINCE TO: 213000 CHANGZHOU, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141231 Address after: 213000 Jiangsu city of Changzhou province Xinbei District Xiang Long Yuan building 1203 room 18 Patentee after: Huang Yarong Address before: 237221, No. 35, Xia Jie Qiao street, Mount Holyoke County, Anhui Patentee before: Sun Xia |
|
ASS | Succession or assignment of patent right |
Owner name: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO., Free format text: FORMER OWNER: HUANG YARONG Effective date: 20150504 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 213000 CHANGZHOU, JIANGSU PROVINCE TO: 226534 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150504 Address after: 226534 Jiangsu city of Nantong province Rugao City Jiangan town Fu Road No. 166 Patentee after: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO., LTD. Address before: 213000 Jiangsu city of Changzhou province Xinbei District Xiang Long Yuan building 1203 room 18 Patentee before: Huang Yarong |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130717 Termination date: 20160209 |
|
CF01 | Termination of patent right due to non-payment of annual fee |